glp 1 activate ingredients GLP-1 Up GLP-ONE + Receptor Activator |
Description
E.AukrustP.FarupP
Yoshida et al.
10.1210/en.2012-1855 50
93 In the randomized clinical trial STEP-HFpEF, patients who did not have T2D were assigned to either semaglutide 2.4 mg once weekly or placebo and followed for 52 weeks
GLP-1 drugs have been found applicable for various diseases such as cardiovascular disease, NASH, AD, and chronic kidney disease
